Happy New Year and a warm welcome back after the festive break.
With the countdown to midnight over for another year, it’s time to start the final countdown to the biggest week in the biotech calendar, as the 34th Annual JP Morgan Healthcare conference and its associated satellite events kick off in San Francisco next week. Today’s update will therefore focus on what you can expect from the conference – our usual Monday Newscast will be back next week.
For those of you heading out to the States, or interested in what goes on so you can consider the trip next year, our webinar on Wednesday morning will provide more details on what to expect from the week and how to maximise your time at the myriad of receptions, meetings and presentations – do register here to join the discussion.
In the meantime, to ease you back into the working week, I’ve outlined some of the important details below.
What is JPM week?
This year marks the 34th Annual JP Morgan Healthcare conference (JPM) – one of the largest and most hectic events of the year for the industry, as thousands of investors and executives from across the healthcare sector descend upon Union Square in San Francisco. Your weekends spent jostling down the busy high street during the pre-Christmas rush should have prepared you nicely for navigating your way across Union Square.
JPM itself is an invitation only event, however a number of other adjacent conferences are also taking place.
The Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives. Now in its eighth year, Biotech Showcase 2016 is expected to attract upwards of 2,100 attendees and is an excellent forum to hear about the latest innovations being developed by emerging companies. It’s run by EBD group who also run BioEurope.
However, all the real action takes place behind closed doors as private meetings set in motion the M&A deals, investments and partnerships that continue to trickle out into the public domain throughout 2016.
Where to go and what to do?
Highlights this year include:
- The art and tactics of getting your fundraise done, a Biotech Showcase pre-event taking place on Sunday 10 January from 13.00-17.00 PST. If you’re arriving in the area early, this workshop is focused on delivering results and securing funding at all levels. Preregistration is required, more information can be found here.
- Informal kick-off drinks with Harriet Fear, One Nucleus, and Steve Bates, BIA. Join myself and Harriet for an evening of informal drinks on Sunday 10 January to kick-off your JPM week. United Life Sciences members may request information by contacting us.
- London and the UK: A global hub for life sciences and investment, a Biotech Showcase workshop taking place on Tuesday 12 January from 08.00-08.55 PST. This workshop will address the questions of the sustainability of this re-emergence, how the structure of the UK market and life science company profiles differ from that of the US and what role London and the UK can play as a global hub for the sector and, in particular, in life science capital raising in the future. I’ll be featuring on the panel alongside Eliot Forster, Paul Tomasic, Daphne Zohar and moderator Chris Mayo.
- The BIA, AstraZeneca and MedImmune Networking Reception, bringing the week to a close as in previous years, from 19.00-21.30 PST. Always a great evening – do contact us for more information.
Those of you not heading to San Francisco, the week is always well covered on Twitter so you can keep up-to-date on any developments. Follow JPM using the hashtag #JPM16 and the Biotech Showcase using #BTS16, or for general updates the BIA Twitter account @BIA_UK.
So arm yourself with a surplus of business cards and don’t forget to pack your phone charger! Most importantly, enjoy the week and I look forward to seeing many of you out in San Francisco, flying the Union Flag for UK bioscience in Union Square.